Today

Agents

Chat

Arena

Discover

More

App

Vivos Therapeutics Q2 Net Income USD -5.523 Million - VVOS News | Rallies

Vivos Therapeutics Q2 Net Income USD -5.523 Million

VVOS•2026-08-14

Q2 financial results

Aug. 14 (Reuters) - Vivos Therapeutics Q2 operating income was USD -4.825 million.

Q2 gross profit: USD 2.953 million

Related News

United Therapeutics CEO Chair Martine Rothblatt disposes of 9,500 shares for $4.81 million

UTHR•2026-08-14

Carl Icahn Cuts Stake In JetBlue, AEP - SEC Filing

JBLU•2026-08-14

Bio Essence swings to Q2 FY26 profit of $270,077; revenue more than doubles to $794,711

•

2026-08-14

Lionheart Holdings Q2 FY26 net loss widens to $4.62 million; operating costs jump to $6.82 million

CUB•2026-08-14

NRx Pharma Q2 FY26 net loss narrows to $16.52 million; revenue rises to $1.1 million

NRXP•2026-08-14